Yes, dynein is a potential target for cancer therapy. Given its critical role in mitosis and intracellular transport, inhibiting dynein function could disrupt the proliferation of cancer cells. Researchers are exploring dynein inhibitors that could specifically target cancer cells without affecting normal cells.
